USE OF 1,2:5,6-DIANHYDROGALACTITOL IN STUDIES ON CELL KINETICS-DIRECTED CHEMOTHERAPY SCHEDULES IN HUMAN TUMORS IN VIVOBARRANCO SC; TOWNSEND CM; COSTANZI JJ et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 7; PP. 2899-2905; BIBL. 22 REF.Article

ENHANCED CELL KILLING THROUGH THE USE OF CELL KINETICS-DIRECTED TREATMENT SCHEDULES FOR TWO-DRUG COMBINATIONS IN VITROBARRANCO SC; MAY JT; BOERWINKLE W et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 7; PP. 2894-2898; BIBL. 9 REF.Article

INFLUENCE OF DIANHYDROGALACTITOL ON SOME PLATELET FUNCTIONS IN VITROKUBISZ P; SEGHIER F; KLENER P et al.1981; ACTA HAEMATOL.; ISSN 0001-5792; CHE; DA. 1981; VOL. 66; NO 1; PP. 27-30; BIBL. 15 REF.Article

SURVIVAL AND PHASE SENSITIVITY OF HELA CELLS TREATED WITH DIANHYDROGALACTITOL (NSC-132313).PALYI I.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 3; PP. 493-499; BIBL. 21 REF.Article

GAS-CHROMATOGRAPHIC ANALYSIS FOR 1,2:5,6-DIANHYDROGALACTITOL, AN ANTI-NEOPLASTIC AGENT, IN PLASMA.KIMURA T; STERNSON LA; HIGUCHI T et al.1976; CLIN. CHEM.; U.S.A.; DA. 1976; VOL. 22; NO 10; PP. 1639-1643; BIBL. 9 REF.Article

EFFECT OF PHENOBARBITAL ON THE TOXICITY AND ANTITUMOR ACTIVITY OF DIBROMODULCITOL AND DIANHYDROGALACTITOLGATI E; SOMFAI RELLE S.1982; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1982; VOL. 32; NO 2; PP. 149-151; ABS. GER; BIBL. 20 REF.Article

PHASE I STUDY OF A FIVE-DAY INTERMITTENT SCHEDULE FOR 1,2: 5,6-DIANHYDROGALACTITOL (NSC-132313).EAGAN RT; MOERTEL CG; HAHN RG et al.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 56; NO 1; PP. 179-181; BIBL. 5 REF.Article

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF DIANHYDROGALACTITOL IN PLASMA BY DERIVATIZATION WITH SODIUM DIETHYLDITHIOCARBAMATE.MUNGER D; STERNSON LA; REPTA AJ et al.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 143; NO 4; PP. 375-382; BIBL. 8 REF.Article

CLINICAL TRIALS WITH THE HEXITOL DERIVATIVES IN THE U.S.CHIUTEN DF; ROZENCWEIG M; VON HOFF DD et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 3; PP. 442-451; BIBL. 68 REF.Article

ACUTE EFFECT OF ENDOGENOUS INHIBITORS AND EXOGENOUS CYTOSTATICS ON THE ULTRASTRUCTURE OF BONE MARROW CELLS. I. SINGLE DOSE OF 1,2:5,6-DIANHYDROGALACTITOL (DAD).BALAZS A.1976; HAEMATOLOGIA; HONGR.; DA. 1976; VOL. 10; NO 3-4; PP. 433-444; BIBL. 1 P. 1/2Article

A PRELIMINARY PHARMACOKINETIC STUDY OF DIANHYDROGALACTITOL (NSC-132313) DISPOSITION IN THE DOG.KIMURA T; STERNSON LA; STELLA VJ et al.1977; J. NATION. CANCER INST.; U.S.A.; DA. 1977; VOL. 58; NO 5; PP. 1311-1314; BIBL. 8 REF.Article

DIANHYDROGALACTITOL IN THE TREATMENT OF CHILDREN WITH PRIMARY BRAIN TUMORSWIENBLATT ME; ORTEGA JA; HIGGINS GR et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 9-10; PP. 923-924; BIBL. 5 REF.Article

PHASE I EVALUATION OF THE COMBINATION 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA (BCNU; NSC-409962) AND DIANHYDROGALACTITOL (DAG; NSC-132313) IN PATIENTS WITH ADVANCED NEOPLASTIC DISEASESCREAGAN ET; EAGAN RT; RUBIN J et al.1979; MED. PEDIATR. ONCOL.; USA; DA. 1979; VOL. 7; NO 2; PP. 179-180; BIBL. 7 REF.Article

PHASE II TRIAL OF DIANHYDROGALACTITOL IN METASTATIC MALIGNANT MELANOMA: A SOUTHWEST ONCOLOGY GROUP STUDYTHIGPEN JT; AL SARRAF M; HEWLETT JS et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 4; PP. 525-528; BIBL. 11 REF.Article

PRECLINICAL TOXICOLOGIC EVALUATION OF DIANHYDROGALACTITOL IN DOGS AND MONKEYS.FOLK RM; PAVKOV KL; THAKE DC et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 10; PP. 1585-1589; BIBL. 5 REF.Article

A ROLE OF CIS-DICHLORODIAMMINEPLATINUM (II) IN SQUAMOUS CELL LUNG CANCEREAGAN RT; FLEMING TR; FRYTAK S et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 1; PP. 87-91; BIBL. 14 REF.Article

DIANHYDROGALACTITOL (NSC-132313): PHASE II STUDY IN SOLID TUMORS: A REPORT OF THE E.O.R.T.C. EARLY CLINICAL TRIAL COOPERATIVE GROUPDE JAGER R; BRUGAROLAS A; HANSEN H et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 7; PP. 971-974; BIBL. 10 REF.Article

Mono- und Dioxetane von 2,5-Anhydroalditolen, Synthesen und Reaktionen = Mono- et dioxétannes d'anhydro-2,5 alditols: synthèses et réactions = Mono- and dioxetanes of 2,5-anhydroalditols: syntheses and reactionsKÖLL, P; OELTING, M.Liebigs Annalen der Chemie. 1987, Num 3, pp 205-214, issn 0170-2041Article

2,5:3,4-Dianhydro-1,6-dideoxy-6-(trimethylamino)-D-allitol and -D-galactitolKUSZMANN, J.Carbohydrate research. 1985, Vol 142, Num 1, pp 71-84, issn 0008-6215Article

IN VIVO STUDY ON ALKYLATION SITE IN DNA BY THE BIFUNCTIONAL DIANHYDROGALACTITOLINSTITORIS E.1981; CHEM.-BIOL. INTERACT.; ISSN 0009-2797; NLD; DA. 1981; VOL. 35; NO 2; PP. 207-216; BIBL. 19 REF.Article

DERIVATIVES OF 2,3-ANHYDRO-DL-THREITOL, 2,3-ANHYDROERYTHRITOL, 2,3:4,5-DIANHYDROGALACTITOL, AND 2,3:4,5-DIANHYDROALLITOL.SCHNEIDER G; HORVATH T; SOHAR P et al.1977; CARBOHYD. RES.; NETHERL.; DA. 1977; VOL. 56; NO 1; PP. 43-52; BIBL. 19 REF.Article

TOXICITY, ANTITUMOUR AND HAEMATOLOGICAL EFFECTS OF 1,2-ANHYDRO-6-BROMOGALACTITOL AND D-MANNITOL: A COMPARISON WITH THE RELATED DIBROMO- AND DIANHYDRO-DERIVATIVESHORVATH IP; SOMFAI RELLE S; HEGEDUES L et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 6; PP. 573-577; BIBL. 17 REF.Article

PHASE II EVALUATION OF DIANHYDROGALACTITOL IN LUNG CANCER: A SOUTHWEST ONCOLOGY GROUP STUDYHAAS CD; BAKER L; THIGPEN T et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 1-2; PP. 115-117; BIBL. 4 REF.Article

CHEMOTHERAPEUTIC SENSITIVITY OF HUMAN COLORECTAL TUMOR XENOGRAFTSKOPPER L; LAPIS K; HEGEDUES C et al.1980; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1980; VOL. 37; SUPPL. 1; PP. 42-50; BIBL. 18 REF.Article

LEYDIG CELL DYSFUNCTION AND GYNAECOMASTIA IN ADULT MALES TREATED WITH ALKYLATING AGENTSFRIEDMAN NM; PLYMATE SR.1980; CLIN. ENDOCRINOL.; GBR; DA. 1980; VOL. 12; NO 6; PP. 553-556; BIBL. 15 REF.Article